Cloudbreak Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	-	10	-	-
Other Revenue	0.25	0.21	0.88	0.47
Revenue	0.25	10.21	0.88	0.47
Revenue Growth (YoY)	-97.52%	1060.68%	86.84%	-
Gross Profit	0.25	10.21	0.88	0.47
Selling, General & Admin	40.9	9.49	11.28	8.91
Research & Development	66.8	37.95	27.49	15.29
Other Operating Expenses	-0.27	0	-0.01	-0.04
Operating Expenses	107.43	47.44	38.76	24.16
Operating Income	-107.18	-37.22	-37.88	-23.69
Interest Expense	-0.02	-0.03	-0.28	-0.03
Interest & Investment Income	1.16	2.03	3.87	1.6
Currency Exchange Gain (Loss)	-0.36	0.65	0.66	0.62
Other Non Operating Income (Expenses)	38.42	-63.72	-95.78	-45.31
EBT Excluding Unusual Items	-67.98	-98.3	-129.4	-66.81
Gain (Loss) on Sale of Investments	0.21	-	-	0.06
Gain (Loss) on Sale of Assets	-	-	-	-0
Pretax Income	-67.77	-98.3	-129.4	-66.76
Income Tax Expense	-0.11	0.83	0.02	0.08
Net Income	-67.66	-99.13	-129.42	-66.84
Net Income to Common	-67.66	-99.13	-129.42	-66.84
Shares Outstanding (Basic)	657	475	463	459
Shares Outstanding (Diluted)	657	475	463	459
Shares Change (YoY)	38.15%	2.78%	0.86%	-
EPS (Basic)	-0.10	-0.21	-0.28	-0.15
EPS (Diluted)	-0.10	-0.21	-0.28	-0.15
Free Cash Flow	-51.74	-26.68	-23.06	-20.83
Free Cash Flow Per Share	-0.08	-0.06	-0.05	-0.04
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	-42363.24%	-364.43%	-4304.20%	-5029.09%
Profit Margin	-26743.08%	-970.53%	-14706.59%	-14190.66%
Free Cash Flow Margin	-20449.01%	-261.18%	-2620.68%	-4422.08%
EBITDA	-106.92	-36.35	-37.38	-23.55
D&A For EBITDA	0.26	0.87	0.5	0.14
EBIT	-107.18	-37.22	-37.88	-23.69